A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Elismetrep (K-304) in the Treatment of Migraine
Clinical trial NCT06848075 · COMPLETED
Trial details
- NCT number
- NCT06848075
- Sponsor
- Kallyope Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-05
- Primary completion
- 2025-08-11
- Enrollment
- 431
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.